Faruqi & Faruqi, LLP Is Investigating Arch Chemicals, Inc.

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Arch Chemicals, Inc. (“Arch Chemicals” or the “Company”) (NYSE: ARJ) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Lonza Group Ltd, one of the world’s leading suppliers to the pharmaceutical, healthcare and life science industries, in an all cash deal valued at approximately $1.4 billion. Under the terms of the proposed transaction, Arch Chemicals’ shareholders will receive $47.20 in cash. The proposed transaction is structured as a tender offer and may be effectuated without a shareholder vote.